Twenty-six scientists from the Scientific Advisory Group for Emergencies (SAGE), who provided guidance to the UK government during the Covid pandemic, did not disclose that they had received over £200 million in grants from a major pharmaceutical investor. This information raises concerns about potential conflicts of interest among the advisors.
The undisclosed financial support from the investor, one of the largest in the pharmaceutical sector, has come to light, prompting scrutiny of the scientists" impartiality during their advisory roles. The lack of transparency regarding these grants could impact public trust in the guidance provided during a critical time in public health.
For further context on related issues, see our coverage of recent developments in political accountability and transparency.
The situation underscores the importance of disclosure in scientific advisory roles, particularly when public health decisions are at stake.
Image for Twenty-six SAGE scientists failed to disclose £200 million in grants
